iRhythm
Also, Japan has approved iRhythm's AI-based continuous ECG monitoring system.
The latest clearance is for an algorithm that characterizes how much atrial fibrillation a patient is experiencing over time.
The pair will be targeting patients with asymptomatic or silent atrial fibrillation.
An algorithm trained on a deep neural network was able to perform on par with board certified cardiologist when annotating 12 different types of heart rhythms.